Examining the Bolar exemption and TRIPS compliance in Türkiye as new EU Pharma Package seeks to broaden exemption
Amid the entry of the EU Pharma Package, which aims to broaden the Bolar exemption substantially both in terms of the activities covered and the parties entitled to rely on it, a re-examination of Türkiye’s longstanding interpretation of the Bolar exemption is essential for rights holders.